Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.58 |
| ▸ | CHRM4 known ✓ | P08173 | 2/20 | 0.58 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.58 |
| ▸ | CHRM3 known ✓ | P20309 | 2/20 | 0.58 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 4/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21515338 | 0.86 | CHRM2 (0.74) | TSHRMAPK1MAPTMEN1KMT2A | |
| SCHEMBL5152882 | 0.80 | MEN1 (0.71) | TSHRMAPK1MAPTMEN1KMT2A | |
| SCHEMBL1546073 | 0.80 | TSHR (0.77) | TSHRMAPK1MAPTMEN1KMT2A | |
| SCHEMBL27528408 | 0.80 | MAPK1 (0.55) | TSHRMAPK1MAPTMEN1KMT2A | |
| SCHEMBL29488461 | 0.80 | ALDH1A1 (0.77) | TSHRMAPK1MAPTMEN1KMT2A | |
| SCHEMBL18793809 | 0.79 | TSHR (0.75) | TSHRMAPK1MAPTMEN1KMT2A | |
| SCHEMBL1928973 | 0.79 | TSHR (0.75) | TSHRMAPK1MAPTMEN1KMT2A | |
| SCHEMBL5006023 | 0.79 | TSHR (0.75) | TSHRMAPK1MAPTMEN1KMT2A | |
| SCHEMBL22651884 | 0.79 | MEN1 (0.59) | TSHRMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL6646008 | 0.79 | TSHR (0.75) | TSHRMAPK1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120131972-A | Microsatellite stabilized colorectal cancer combination therapy based on PCSK9 inhibitors | 广东省人民医院 | 2025-06-13 | — | — | CN | claimed |
| CN-122051652-A | Super-surface array antenna with independent and controllable amplitude and phase | 东南大学 | 2026-05-15 | — | — | CN | disclosed |
| EP-4109005-B1 | AIR CONDITIONER | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-08-13 | — | — | EP | disclosed |
| EP-4577306-A1 | COMBINATION CANCER TREATMENT COMPRISING AN ANTI-MSLN/CD137 ANTIBODY AND PD-1/PD-L1 INHIBITOR | Merck Patent GmbH (DE) | 2025-07-02 | — | — | EP | disclosed |
| EP-4578457-A1 | PHARMACEUTICAL FOR TREATING AND/OR PREVENTING CANCER | Toray Industries, Inc. (JP) | 2025-07-02 | — | — | EP | disclosed |
| CN-120131972-A | Microsatellite stabilized colorectal cancer combination therapy based on PCSK9 inhibitors | 广东省人民医院 | 2025-06-13 | — | — | CN | disclosed |
| CN-119836302-A | Combination cancer treatment comprising anti-MSLN/CD 137 antibodies and PD-1/PD-L1 inhibitors | 默克专利股份公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-119768182-A | Medicine for treating and/or preventing cancer | 东丽株式会社 | 2025-04-04 | — | — | CN | disclosed |
| WO-2024206869-A2 | COMBINATION OF HPK1 INHIBITOR AND AXL INHIBITOR IN CANCER THERAPY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-10-03 | — | — | WO | disclosed |
| US-12035818-B2 | Breathable crib | BREATHABLEBABY, LLC (US) | 2024-07-16 | — | — | US | disclosed |
| CN-117708126-A | Comprehensive energy data storage and analysis method | 上海电气集团股份有限公司 | 2024-03-15 | — | — | CN | disclosed |
| WO-2024043252-A1 | PHARMACEUTICAL FOR TREATING AND/OR PREVENTING CANCER | 東レ株式会社 | 2024-02-29 | — | — | WO | disclosed |
| WO-2024042104-A1 | COMBINATION CANCER TREATMENT COMPRISING AN ANTI-MSLN/CD137 ANTIBODY AND PD-1/PD-L1 INHIBITOR | MERCK PATENT GMBH (DE) | 2024-02-29 | — | — | WO | disclosed |
| US-11835428-B2 | Diagnosis control method of air conditioner | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-12-05 | — | — | US | disclosed |
| EP-4109005-A2 | DIAGNOSIS CONTROL METHOD FOR AN AIR CONDITIONER | Samsung Electronics Co., Ltd. (KR) | 2022-12-28 | — | — | EP | disclosed |
| CN-115075149-A | Construction method for erecting large downhill bridge by using guide-beam-free transportation and erection integrated machine | 中铁二局集团有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-20220138586-A1 | MEMORY SYSTEM OF AN ARTIFICIAL NEURAL NETWORK BASED ON A DATA LOCALITY OF AN ARTIFICIAL NEURAL NETWORK | DEEPX CO., LTD. (KR) | 2022-05-05 | — | — | US | disclosed |
| CN-109068655-B | Pesticidal active mixtures of tioxazafen | 巴斯夫欧洲公司 | 2022-05-03 | — | — | CN | disclosed |